Access notes: United States

Regulator, prescription status, reimbursement position and practical access route for United States. Every claim dated, because this changes constantly.

Scope and expiry

Practical access notes for United States: who regulates, what prescription status applies, how reimbursement is decided, and what route people actually use.

Regulatory and prescription position

The Food and Drug Administration licenses products; prescribing and pharmacy practice are regulated at state level. Products in this class are prescription-only.

Coverage and cost

Coverage is the dominant access question and is decided by individual plans rather than nationally. Prior authorisation, step therapy, and exclusion of weight-management indications from a plan's benefit design are all common, and the denial letter tells you which one you are facing.

Pharmaceutical compounding of a drug that is not on the FDA shortage list is substantially constrained, and the compounding landscape changed when supply of licensed products normalised. Any claim about what compounding pharmacies may lawfully prepare needs a date attached.

The route people actually use

Telehealth prescribing is widespread and varies in quality. A model that does not involve a clinician reviewing measurements and history is not a model this community can recommend.

In practice the access question in United States resolves into three sub-questions: whether a prescription can be obtained, whether it will be funded, and whether the product is currently in supply. Those have different answers and different remedies, and conflating them is the commonest reason a member gets stuck.

If funding is the obstacle, the appeal discussion in Access is more useful than another consultation. If supply is the obstacle, the national shortage register — where one exists — is the only source worth reading.

What this page will not help with

This page does not describe how to obtain unlicensed material, and this community does not assist with that. It also does not tell you whether something is legal for you to possess, because that depends on facts about you that a documentation page cannot know.

Research-use-only material is not a licensed medicine in United States or anywhere else we are aware of.

Contributing

Regional pages are maintained by members in the region. If you can confirm or contradict anything here from a primary source, post in the regional category with the source and the date. An undated claim in this area is worse than no claim, and we will ask for the date.